This article is meant to be a brief commentary on how we, at mjn-neuro, have spent so many days working…
mjn-neuro8 April, 2020
This is an article by Paul Warren, originally posted on his LinkedIn account, where he explains his sister's story...
mjn-neuro10 March, 2020
MJN, within the Research and Development Grant program, Horizon2020, Phase 2 of the European Commission, is developing a system of…
mjn-neuro6 March, 2020
Hi Fernando, tell us what did you study and your previous experience before coming to mjn-neuro. Hello! I am an…
mjn-neuro26 February, 2020
This article has been prepared with the publication of Epilepsy Action as a referent. The data is from the United…
mjn-neuro19 February, 2020
On the first days of January, our CEO, David Blánquez has been attending several events in Las Vegas and San…
mjn-neuro5 February, 2020
SCN8A epileptic encephalopathy is caused by a mutation of this gene. It is a very rare pathology, among other reasons,…
mjn-neuro28 January, 2020
The COP25 is being held in Madrid these days. And one of the recurring themes in the conversations held by…
mjn-neuro16 December, 2019
This November we had, again, a month with a lot of movement. For example, they have informed us that for…
mjn-neuro2 December, 2019
